The association between blood coagulation activity and lung function: A population-based study

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Fogarty, Andrew W ^a   Lewis, Sarah A ^a   Mckeever, Tricia M ^a   Lowe, Gordon D O ^b   Clark, Lorna ^c   Britton, John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SYSTEMIC DISEASE; BLOOD; CROSS-SECTIONAL STUDY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOSIS; VITAL CAPACITY;

ADULT; BLOOD COAGULATION; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; THROMBOSIS; VITAL CAPACITY;

EID: 78649513114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015014     Document Type: Article

References (22)

1. Barnes P (2000) Chronic obstructive pulmonary disease. New Eng J Med 343: 269-280.
2. Fletcher C, Peto R, Tinker C, Speizer F (1976) Factors related to the development of airflow obstruction. In: The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press. pp 70-102.
3. Torres-Duque C, Maldonaldo D, Perez-Padilla R, Ezzati M, Viegi G (2008) Biomass fuels and respiratory diseases. Proc Am Thorac Soc 5: 577-590.
4. McKeever T, Scrivener S, Broadfield E, Jones Z, Britton J, et al. (2002) Prospective study of diet and decline in lung function in a general population. Am J Respir Crit Care Med 165: 1299-1303.
5. Begbie M, Wallace G, Shovlin C (2003) Hereditary haemorrhagic telangectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 79: 18-24.
6. Juul K, Tybjaerg-Hansen A, Mortensen J, Lange P, Vestbo J, et al. (2005) Factor V leiden homozygosity, dyspnea, and reduced pulmonary function. Arch Intern Med 165: 2032-2036.
7. Fibrinogen Studies Collaboration (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. JAMA 294: 1799-1809.
8. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nortestgaard B (2001) Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1008-1011.
9. Thyagarajan B, Jacobs D, Apostol G, Smith L, Lewis C, et al. (2006) Plasma fibrinogen and lung function: the CARDIA study. Int J Epidemiol 35: 1001-1008.
10. Jiang R, Burke G, Enright P, Newman A, Margolis H, et al. (2008) Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. pp 602-610.
11. Tuder R, Petrache I (2007) Molecular multitasking in the airspace. Am J Respir Cell Mol Biol 37: 130-134.
12. Wells P, Brill-Edwards P, Stevens P, Panju A, Patel A, et al. (1995) A novel and rapid whole-blood assay for d-dimer in patients with clinically suspected deep vein thrombosis. Circulation 91: 2184-2187.
13. Britton J, Pavord I, Richards K, Wisniewski A, Knox A, et al. (1994) Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet 344: 357-362.
14. Danesh J, Whincup G, Walker M, Lennon L, Thomson A, et al. (2001) Fibrin D-dimer and coronary heart disease. Circulation 103: 2323-2327.
15. Fogarty A, Jones S, Britton J, Lewis S, McKeever T (2007) Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62: 515-520.
16. Lowe G, Sweetnam P, Yarnell J, Rumley A, Rumley C, et al. (2004) C-reactive protein, Fibrin D-dimer, and risk of ischemic heart disease. Arterioscler Thromb Vasc Biol 24: 1957-1962.
17. Sin D, Wu L, Man P (2005) The relationship between reduced lung function and cardiovascular mortality. Chest 127: 1952-1959.
18. Seaton A, MacNee W, Donaldson K, Godden D (1995) Particulate air pollution and acute health effects. Lancet 345: 176-178.
19. Calderon-Garciduenas A, Fordham L, Chung C, Garcia C, Osnaya N, et al. (2001) Canines as sentinal species for assessing chronic exposures to air pollutants: Part 1. Respiratory Physiology. Toxicological sciences 61: 342-355.
20. Gauderman W, Avol E, Gilliland F, Vora H, Thomas D, et al. (2004) The effect of air pollution on lung development from 10 to 18 years of age. New Eng J Med 351: 1057-1067.
21. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, et al. (2004) Association of bronchial hyperrresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 59: 892-896.
22. Aronson D, Roterman I, Yigla M, Kerner A, Avizohar O, et al. (2006) Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 174: 626-632.